UPLOAD Filing
Sunshine Biopharma Inc.
Date: Aug. 11, 2025 · CIK: 0001402328 · Accession: 0000000000-25-008396
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289230
Letter
Re: Sunshine Biopharma Inc. Registration Statement on Form S-1 Filed August 5, 2025 File No. 333-289230 Dear Dr. Steve N. Slilaty:
August 11, 2025
Dr. Steve N. Slilaty Chief Executive Officer and Director Sunshine Biopharma Inc. 333 Las Olas Way, CU4 Suite 433 Fort Lauderdale, FL 33301
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jeff Cahlon, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 11, 2025 Dr. Steve N. Slilaty Chief Executive Officer and Director Sunshine Biopharma Inc. 333 Las Olas Way, CU4 Suite 433 Fort Lauderdale, FL 33301 Re: Sunshine Biopharma Inc. Registration Statement on Form S-1 Filed August 5, 2025 File No. 333-289230 Dear Dr. Steve N. Slilaty: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeff Cahlon, Esq. </TEXT> </DOCUMENT>